scPharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Scpharmaceuticals

12/05/2021 17:34

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly adjusted
loss of 26 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 30 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* scPharmaceuticals Inc's reported EPS for the quarter was a
loss of 26 cents​.
* The mean earnings estimate of analysts had risen by
about 18.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* scPharmaceuticals Inc shares had fallen by 11.4% this
quarter and gained 11.3% so far this year.
* The company reported a quarterly loss of $7.1 million.
* Wall Street's median 12-month price target for
scPharmaceuticals Inc is $11.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 12 at 04:34 p.m. GMT.
​All figures in US dollars